116 related articles for article (PubMed ID: 11849208)
1. Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.
Wright AM; Paterson AR; Sowa B; Akabutu JJ; Grundy PE; Gati WP
Br J Haematol; 2002 Mar; 116(3):528-37. PubMed ID: 11849208
[TBL] [Abstract][Full Text] [Related]
2. Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
Gati WP; Paterson AR; Belch AR; Chlumecky V; Larratt LM; Mant MJ; Turner AR
Leuk Lymphoma; 1998 Dec; 32(1-2):45-54. PubMed ID: 10037000
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
Gati WP; Paterson AR; Larratt LM; Turner AR; Belch AR
Blood; 1997 Jul; 90(1):346-53. PubMed ID: 9207471
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.
Han T; Fernandez M; Chou TC; Agarwal RP
J Cancer Res Clin Oncol; 2005 Sep; 131(9):609-16. PubMed ID: 16044347
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of retention and cytotoxicity of 2-chlorodeoxyadenosine in cultured human leukemic lymphoblasts by nitrobenzylthioinosine, an inhibitor of equilibrative nucleoside transport.
Wright AM; Gati WP; Paterson AR
Leukemia; 2000 Jan; 14(1):52-60. PubMed ID: 10637477
[TBL] [Abstract][Full Text] [Related]
6. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro.
Petersen AJ; Brown RD; Gibson J; Pope B; Luo XF; Schutz L; Wiley JS; Joshua DE
Eur J Haematol; 1996 Apr; 56(4):213-20. PubMed ID: 8641389
[TBL] [Abstract][Full Text] [Related]
8. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
[TBL] [Abstract][Full Text] [Related]
11. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
[TBL] [Abstract][Full Text] [Related]
12. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
[TBL] [Abstract][Full Text] [Related]
13. A new fluorescent probe for the equilibrative inhibitor-sensitive nucleoside transporter. 5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine (SAENTA)-chi 2-fluorescein.
Wiley JS; Brocklebank AM; Snook MB; Jamieson GP; Sawyer WH; Craik JD; Cass CE; Robins MJ; McAdam DP; Paterson AR
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):667-72. PubMed ID: 1996965
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
Gourdeau H; Bibeau L; Ouellet F; Custeau D; Bernier L; Bowlin T
Cancer Chemother Pharmacol; 2001 Mar; 47(3):236-40. PubMed ID: 11320667
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide excision repair-deficient human cells in culture exhibit decreased survival after 2-chlorodeoxyadenosine treatment.
Lawrenzi J; Bunnell A; Hentosh P
Anticancer Res; 2003; 23(4):3141-5. PubMed ID: 12926046
[TBL] [Abstract][Full Text] [Related]
16. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
Jamieson GP; Brocklebank AM; Snook MB; Sawyer WH; Buolamwini JK; Paterson AR; Wiley JS
Cytometry; 1993; 14(1):32-8. PubMed ID: 8432200
[TBL] [Abstract][Full Text] [Related]
18. Activation of deoxycytidine kinase by various nucleoside analogues.
Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
[TBL] [Abstract][Full Text] [Related]
19. Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.
Ohta T; Hori H; Ogawa M; Miyahara M; Kawasaki H; Taniguchi N; Komada Y
Oncol Rep; 2004 Nov; 12(5):1115-20. PubMed ID: 15492802
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.
Pressacco J; Wiley JS; Jamieson GP; Erlichman C; Hedley DW
Br J Cancer; 1995 Oct; 72(4):939-42. PubMed ID: 7547244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]